Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
We describe 24 consecutive patients with cervical cancer stage III or IV who received palliative urinary diversion by percutaneous nephrostomy. All patients had proven malignant ureteric obstruction, uremia and failed ureteric stenting. 11 of 17 patients with extensive primary cancer and local lymph node involvement had an acceptable quality of life for 2 or more months while the mean survival was 5.6 months. Patients with disseminated metastasizing cancer were not satisfactorily served by nephrostomy.
Emmert
C
C
Department of Obstetrics and Gynecology, University of Leipzig, Germany.
Rassler
J
J
Köhler
U
U
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous; D010166:Palliative Care; D011788:Quality of Life; D014517:Ureteral Obstruction / Q000209:etiology / Q000401:mortality / Q000601:surgery*; D002583:Uterine Cervical Neoplasms / Q000150:complications* / Q000401:mortality* / Q000523:psychology